Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?14.71

?14.71

 
WKN: A1W77U / Symbol: KPTI / Name: Karyopharm / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€16.51
04.11.25
-
buy
€12.91
13.10.25
-
buy
€10.31
09.10.25
-
buy
€18.04
09.10.25
-
buy
€21.52
12.08.25
-
buy
€23.13
11.07.25
-
buy
Your prediction

Karyopharm Therapeutics Inc. Stock

With 14 Buy predictions and not the single Sell prediction the community is currently very high on Karyopharm Therapeutics Inc..
Based on the current price of 0.54 € the target price of 14 € shows a potential of 2486.84% for Karyopharm Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Karyopharm Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.

Pros and Cons of Karyopharm Therapeutics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Karyopharm Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Karyopharm Therapeutics Inc. - - - - - - -
Ardelyx Inc. 5.570% 2.840% 1.187% 5.509% 6.465% 176.349% -3.856%
Krystal Biotech 0.330% 3.678% 18.962% 25.776% 37.057% 193.803% -
Evolus Inc -4.200% -1.724% -8.065% -47.706% -45.714% -18.571% 88.742%

Comments

Prediction Buy
Perf. (%) -
Target price 16.509
Change
Ends at 04.11.26

Karyopharm Therapeutics (NASDAQ:KPTI) had its price target lowered by analysts at Royal Bank Of Canada from $30.00 to $19.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 12.909
Change
Ends at 13.10.26

Karyopharm Therapeutics (NASDAQ:KPTI) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock.
Ratings data for KPTI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 10.309
Change
Ends at 09.10.26

Karyopharm Therapeutics (NASDAQ:KPTI) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, down previously from $15.00.
Ratings data for KPTI provided by MarketBeat
Show more